Physician profile
Casey Ward
NPI 1043751845
$3,572.96
in general payments reported to CMS, 2019-2025
35 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,070 · 2022: $1,003 · 2023: $406 · 2024: $747 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Education: $46.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.83 |
| Education | $46.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $438.13 | 2021-2025 | Ingrezza, Ongentys |
| Genzyme Corporation | $360.34 | 2021-2023 | |
| Abbvie INC. | $286.79 | 2021-2024 | |
| Lundbeck LLC | $284.92 | 2021-2023 | Vyepti |
| Jazz Pharmaceuticals INC. | $262.31 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $245.45 | 2021-2025 | Hyqvia |
| Ucb, INC. | $183.46 | 2021-2024 | Rystiggo |
| Merz Pharmaceuticals, LLC | $162.80 | 2021 | |
| Scilex Pharmaceuticals INC. | $155.63 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $153.95 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $152.26 | 2021 | |
| Pfizer INC. | $118.24 | 2023-2025 | |
| Harmony Biosciences LLC | $91.51 | 2025 | |
| Grifols USA, LLC | $86.52 | 2021-2023 | Gamunex-C |
| Protega Pharmaceutials INC | $73.29 | 2023 | Roxybond |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $69.60 | 2024 | Remede System |
| Horizon Therapeutics Plc | $59.94 | 2021-2022 | |
| Emd Serono, INC. | $44.46 | 2023 | Mavenclad |
| Upsher-Smith Laboratories LLC | $40.56 | 2022-2023 | |
| Almatica Pharma LLC | $37.70 | 2022-2023 | Gralise |
| Inspire Medical Systems, INC. | $28.09 | 2024 | Inspire |
| Vertex Pharmaceuticals Incorporated | $26.18 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $20.00 | 2023 | Fycompa |
| Allergan, INC. | $19.60 | 2021 | |
| Argenx US, INC. | $18.35 | 2025 | Vyvgart |
| Adamas Pharmaceuticals, INC. | $17.95 | 2021 | |
| Grt US Holding, INC. | $17.94 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.22 | 2022 | |
| Virtus Pharmaceuticals LLC | $15.64 | 2021 | |
| Neurelis, INC. | $15.64 | 2022 | |
| Forte Bio-Pharma LLC | $15.54 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $14.88 | 2024 | Nuedexta |
| Currax Pharmaceuticals LLC | $13.79 | 2021 | |
| Csl Behring | $13.04 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.